Mainz Biomed NV (MYNZ)
(Delayed Data from NSDQ)
$0.36 USD
+0.01 (3.40%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $0.36 0.00 (0.28%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Cash flow Statements
Fiscal Year End for Mainz Biomed NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -26.30 | -26.39 | -11.69 | -0.59 | NA |
Depreciation/Amortization & Depletion | 0.87 | 0.38 | 0.07 | 0.06 | NA |
Net Change from Assets/Liabilities | -0.06 | 1.39 | -0.14 | 0.06 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 3.56 | 9.85 | 8.54 | 0.00 | NA |
Net Cash From Operating Activities | -21.94 | -14.77 | -3.22 | -0.47 | NA |
Property & Equipment | -1.20 | -0.66 | -0.02 | -0.01 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 1.22 | 0.00 | NA |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | -0.70 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | -1.90 | -0.66 | 1.20 | -0.01 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 6.39 | 24.25 | 10.43 | 0.00 | NA |
Issuance (Repayment) of Debt | 9.02 | 0.00 | 0.01 | 0.01 | NA |
Increase (Decrease) Short-Term Debt | -0.25 | -0.30 | -0.06 | -0.01 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | -0.93 | 0.00 | 0.24 | 0.40 | NA |
Net Cash from Financing Activities | 14.23 | 23.94 | 10.61 | 0.40 | NA |
Effect of Exchange Rate Changes | -0.46 | -0.10 | 0.01 | 0.00 | NA |
Net Change In Cash & Equivalents | -10.07 | 8.41 | 8.60 | -0.08 | NA |
Cash at Beginning of Period | 17.14 | 8.73 | 0.12 | 0.20 | NA |
Cash at End of Period | 7.07 | 17.14 | 8.73 | 0.12 | NA |
Diluted Net EPS | -1.62 | -1.86 | -1.62 | NA | NA |
Fiscal Year End for Mainz Biomed NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | NA | -26.30 | -21.11 | -14.81 |
Depreciation/Amortization & Depletion | NA | NA | 0.87 | 0.66 | 0.46 |
Net Change from Assets/Liabilities | NA | NA | -0.06 | -0.30 | 1.38 |
Net Cash from Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | NA | 3.56 | 3.47 | 2.19 |
Net Cash From Operating Activities | NA | NA | -21.94 | -17.28 | -10.78 |
Property & Equipment | NA | NA | -1.20 | -1.04 | -1.02 |
Acquisition/ Disposition of Subsidiaries | NA | NA | 0.00 | 0.00 | 0.00 |
Investments | NA | NA | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | NA | -0.70 | -0.60 | -0.50 |
Net Cash from Investing Activities | NA | NA | -1.90 | -1.64 | -1.52 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | NA | 6.39 | 1.89 | 1.89 |
Issuance (Repayment) of Debt | NA | NA | 9.02 | 10.12 | 5.06 |
Increase (Decrease) Short-Term Debt | NA | NA | -0.25 | -0.32 | -0.76 |
Payment of Dividends & Other Distributions | NA | NA | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | NA | -0.93 | -0.93 | 0.00 |
Net Cash from Financing Activities | NA | NA | 14.23 | 10.76 | 6.19 |
Effect of Exchange Rate Changes | NA | NA | -0.46 | 0.34 | -0.12 |
Net Change In Cash & Equivalents | NA | NA | -10.07 | -7.82 | -6.23 |
Cash at Beginning of Period | NA | NA | 17.14 | 17.14 | 17.14 |
Cash at End of Period | NA | NA | 7.07 | 9.32 | 10.91 |
Diluted Net EPS | NA | NA | -0.22 | -0.39 | -0.56 |